Holen Sie sich die Stockscreener-App
588.93
0.14%
0.645
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$588.29
Offen:
$582.55
24-Stunden-Volumen:
35,599
Relative Volume:
0.02
Marktkapitalisierung:
$217.82B
Einnahmen:
$45.20B
Nettoeinkommen (Verlust:
$6.87B
KGV:
32.38
EPS:
18.1888
Netto-Cashflow:
$6.75B
1W Leistung:
-1.77%
1M Leistung:
+10.63%
6M Leistung:
+17.45%
1J Leistung:
+20.47%
1-Tages-Spanne:
$580.00
$590.48
1-Wochen-Bereich:
$580.00
$606.75
52-Wochen-Spanne:
$435.27
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
589.10 | 217.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.51 | 142.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
308.40 | 44.67B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
547.37 | 43.41B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.59 | 41.95B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Oppenheimer Asset Management Inc. Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Laraway Financial Advisors Inc Invests $1.10 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
12,002 Shares in Thermo Fisher Scientific Inc. $TMO Acquired by Trifecta Capital Advisors LLC - MarketBeat
Merit Financial Group LLC Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Merit Financial Group LLC Buys 7,125 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Vaquero Private Wealth Ltd. Invests $989,000 in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cornerstone Capital Inc. Invests $24.57 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Farther Finance Advisors LLC Has $6.57 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Bryn Mawr Trust Advisors LLC Takes Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Diversified Trust Co. Acquires 7,155 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Everett Harris & Co. CA Takes $7.92 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Introduces InstaFlux Workflow - foodengineeringmag.com
Thermo Fisher CEO Casper sells $8.6m in stock, exercises options - Investing.com India
Thermo Fisher chairman & CEO Marc Casper sells $8.6m in company stock - Investing.com India
Thermo Fisher Eyes 15-20% Growth in India Customer Base Over Next 5 Years Amid Biopharma Boom - Medical Dialogues
Simplify Asset Management Inc. Buys 5,670 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Union Bancaire Privee UBP SA Grows Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside (NYSE:TMO) - Seeking Alpha
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 5,437 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Asio Capital LLC Lowers Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Matrix Asset Advisors Inc. NY - MarketBeat
Prospera Financial Services Inc Purchases 1,763 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Canoe Financial LP Buys 148,999 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific completes sale of its microbiology business - chemengonline.com
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Wealth Enhancement Advisory Services LLC - MarketBeat
QRG Capital Management Inc. Raises Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Brookstone Capital Management Has $993,000 Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fenimore Asset Management Inc Invests $3.06 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Envetec Appoints Patrick S. Jones as Independent Director - Yahoo Finance
Thermo Fisher EVP Michael D. Shafer Reports Stock Option Exercises and Sales on August 11, 2026 - kalkinemedia.com
Fund Update: 3,029,037 THERMO FISHER SCIENTIFIC (TMO) shares added to DODGE & COX portfolio - Quiver Quantitative
Michael Shafer Sells 25,500 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
Thermo Fisher Scientific Insider Sold Shares Worth $15,300,000, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher Scientific (TMO) EVP exercises options, then sells 25,500 shares - Stock Titan
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now? - The Motley Fool
Axinn Advises Thermo Fisher Scientific On Completed $1.075 Billion Sale Of Microbiology Business To Astorg - Mondaq
Thermo Fisher vende su división de microbiología por más de $1,000 millones - WFMZ.com
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm - MedTech Dive
Thermo Fisher sells microbiology business for $1.08 billion - WFMZ.com
Y Intercept Hong Kong Ltd Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fund Update: 22,749 THERMO FISHER SCIENTIFIC (TMO) shares added to Magellan Asset Management Ltd portfolio - Quiver Quantitative
Howland Capital Management LLC Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples - BioPharma APAC
Is Thermo Fisher Scientific Inc. (NYSE:TMO) Potentially Undervalued? - Moomoo
Thermo Fisher Beat Estimates by $300 Million in Q2. Is the Recovery Finally Here? - TIKR.com
Astorg VIII, SLP, managed by Astorg Asset Management S A.R.L. completed the acquisition of Global Microbiology Business from Thermo Fisher Scientific Inc.. - marketscreener.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Thermo Fisher Scientific Inc-Aktie (TMO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shafer Michael D | Executive Vice President |
Aug 11 '26 |
Sale |
600.00 |
25,500 |
15,300,000 |
20,994 |
0.15%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):